相关实验视频
Updated: Jan 15, 2026

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.6K
[对德国利益相关者而言,以自我帮助为导向的瘤研究的附加价值]
Christopher Kofahl1, Stefanie Houwaart2,3, Otmar Kodalle4
1Institut für Medizinische Soziologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland. kofahl@uke.de.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|January 14, 2026
概括
通过自助小组 (SHG) 和组织 (SHO) 整合患者的见解,提高了癌症研究的相关性和质量. 最佳的协作涉及患者作为平等的研究伙伴,使所有利益相关者受益.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 患者倡导 患者倡导
背景情况:
- 癌症研究越来越认识到需要纳入患者的观点超越治疗结果.
- 生活质量和心理健康是癌症患者体验的关键方面.
- 自助团体 (SHG) 和组织 (SHO) 对于患者参与和代表至关重要.
研究的目的:
- 检查将患者经验和知识纳入癌症研究的整合.
- 探索多方利益相关者的观点,以自我帮助为导向的癌症研究.
- 确定影响研究和自助倡议之间成功合作的因素.
主要方法:
- 分析癌症自我帮助在患者参与和代表方面的作用.
- 评估不同程度的SHG/SHO参与研究项目 (从"没有"到"通过"自助).
- 讨论合作研究的先决条件,成功因素和障碍.
主要成果:
- 参与SHG/SHO可以显著提高瘤学研究的可行性,质量和患者相关性.
- 参与性,合作性,联合性和平等性研究被认为是最民主和最优的方法.
- 这种协作模式为研究人员,患者,亲属,医疗保健专业人员和社会带来了优势.
结论:
- 以自助为导向的研究,特别是参与性研究,为癌症研究和患者护理带来了巨大的好处.
- 成功的整合需要解决特定的先决条件,克服现有的合作障碍.
- 患者参与研究的增强将导致更相关,更有影响力的瘤学研究.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

